ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Of Smokers Screened With CT In Study, 7% Have Lung Cancer

December 31, 2004

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

When Is A Cancer Cured? NCI Suggest One-Year Survival Rates Useful In Determining Advances

August 1, 1975

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979

NIH Revises Application Receipt Dates

November 22, 1985

Center Grant Review Tougher, Yarbro Insists

May 23, 1975